Geminin overexpression induces mammary tumors via suppressing cytokinesis

Oncotarget

Volumn 2, Issue 12, 2011, Pages 1011-1027

  Blanchard, Zannel ^a   Malik, Rohit ^a   Mullins, Nicole ^a   Maric, Christine ^a   Luk, Hugh ^a   Horio, David ^a   Hernandez, Brenda ^a   Killeen, Jeffrey ^a   ElShamy, Wael M ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Geminin overexpression induces mammary tumors

Indexed keywords

4 (4 (N BENZOYLAMINO)ANILINO) 6 METHOXY 7 (3 (1 MORPHOLINO)PROPOXY)QUINAZOLINE; 4-(4-(N-BENZOYLAMINO)ANILINO)-6-METHOXY-7-(3-(1-MORPHOLINO)PROPOXY)QUINAZOLINE; AURORA KINASE; BENZAMIDE DERIVATIVE; CELL CYCLE PROTEIN; GMNN PROTEIN, HUMAN; HISTONE; INCENP PROTEIN, MOUSE; NONHISTONE PROTEIN; PROTEIN SERINE THREONINE KINASE; QUINAZOLINE DERIVATIVE;

ANEUPLOIDY; ANIMAL; ARTICLE; CELL CYCLE; CHROMATIN; CYTOKINESIS; DRUG ANTAGONISM; EXPERIMENTAL NEOPLASM; FEMALE; GENETICS; HUMAN; METABOLISM; MITOSIS; MITOSIS SPINDLE; MOUSE; MOUSE MUTANT; ONCOGENE; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

ANEUPLOIDY; ANIMALS; BENZAMIDES; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; CYTOKINESIS; FEMALE; HISTONES; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, SCID; MITOSIS; MITOTIC SPINDLE APPARATUS; ONCOGENES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; QUINAZOLINES;

EID: 84863004171     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.363     Document Type: Article

References (46)

1. Storchova Z, Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol. 2004; 5: 45-54.
2. Eggert U, Mitchison T, Field C. Animal cytokinesis: from parts list to mechanisms. Ann Rev Biochem. 2006; 75: 543- 566.
3. Ganem N, Storchova Z, Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev. 2007; 17: 157-162.
4. Guizetti J, Gerlich D. Cytokinetic abscission in animal cells. Semin Cell Dev Biol. 2010; 21(9): 909-916.
5. Cimini D, Wan X, Hirel C, Salmon E. Aurora kinase promotes turnover of kinetochore microtubules to reduce chromosome segregation errors. Curr Biol. 2006; 16: 1711- 1718.
6. Norden C, Mendoza M, Dobbelaere J, Kotwaliwale C, Biggins S, Barral Y. The NoCut pathway links completion of cytokinesis to spindle midzone function to prevent chromosome breakage. Cell. 2006; 125: 85-98.
7. Ruchaud S, Carmena M, Earnshaw C. Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol. 2007; 8: 798-812.
8. Xu Z, Ogawa H, Vagnarelli P, Bergmann J, Hudson D, Ruchaud S, Fukagawa T, Earnshaw W, Samejima K. INCENP-aurora B interactions modulate kinase activity and chromosome passenger complex localization. J Cell Biol. 2009; 187(5): 637-653.
9. Wheatley S. Chromosome by-Aurora-ientation during mitosis. Cell Biol Int. 2011; 35(6): 575-578.
10. Ahonen L, Kukkonen A, Pouwels J, Bolton M, Jingle C, Stukenberg P, Kallio M. Perturbation of Incenp function impedes anaphase chromatid movements and chromosomal passenger protein flux at centromeres. Chromosoma. 2009; 118(1): 71-84.
11. Wohlschlegel J, Dwyer B, Dhar S, Cvetic C, Walter J, Dutta A. Inhibition of eukaryotic DNA replication by geminin binding to Cdt1. Science. 2000; 290: 2309-2312.
12. McGarry T, Kirschner M. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell. 1998; 93(6): 1043-5321.
13. Del Bene F, Tessmar-Raible K, Wittbrodt J. Direct interaction of geminin and Six3 in eye development. Nature. 2004; 427(6976): 745-749.
14. Luo L, Yang X, Takihara Y, Knoetgen H, Kessel M. The cell-cycle regulator geminin inhibits Hox function through direct and Polycomb mediated interactions. Nature. 2004; 427(6976): 749-753.
15. Seo S, Herr A, Lim J, Richardson G, Richardson H, Kroll K. Geminin regulates neuronal differentiation by antagonizing Brg1 activity. Genes Dev. 2005; 19(14): 1723-1734.
16. Karamitros D, Kotantaki P, Lygerou Z, Kioussis D, Taraviras S. T cell proliferation and homeostasis: an emerging role for the cell cycle inhibitor geminin. Crit Rev Immunol. 2011; 31(3): 209-231.
17. Wong P, Glozak M, Cao T, Vaziri C, Seto E, Alexandrow M. Chromatin unfolding by Cdt1 regulates MCM loading via opposing functions of HBO1 and HDAC11-geminin. Cell Cycle. 2010; 9(21): 4351-4363.
18. Yang V, Carter S, Hyland S, Tachibana-Konwalski K, Laskey R, Gonzalez M. Geminin escapes degradation in G1 of mouse pluripotent cells and mediates the expression of Oct4, Sox2, and Nanog. Curr Biol. 2011; 21(8): 692-699.
19. McGarry T. Geminin deficiency causes a Chk1-dependent G2 arrest in Xenopus. Mol Biol Cell. 2002; 13(10): 3662- 3671.
20. Nakuci E, Xu M, Pujana M, Valls J, ElShamy WM. Geminin is bound to chromatin in G2/M phase to promote proper cytokinesis. Int J Biochem Cell Biol. 2006; 38(7): 1207-1220.
21. Hara K, Nakayama K, Nakayama K. Geminin is essential for the development of preimplementation mouse embryos. Genes Cells. 2006; 11(11): 1281-1293.
22. Gardner L, Malik R, Shimizu Y, ElShamy, WM. Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation leading to aneuploidy in human mammary epithelial cells. Breast Cancer Res. 2011; 13(53).
23. Montanari M, Boninsegna A, Faraglia B, Coco C, Giordano A, Cittadini A, Sgambato A. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors. J Cell Physiol. 2005; 202(1): 215-22.
24. Wei Y, Yu L, Bowen J, Gorovsky M, Allis C. Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell. 1999; 97(1): 99-109.
25. Delacour-Larose M, Thi M, Dimitrov S, Molla A. Role of survivin phosphorylation by aurora B in mitosis. Cell Cycle. 2007; 6(15): 1878-1885.
26. Elenbaas B, Spirio L, Koerner F, Fleming M, Zimonjic D, Donaher J, Popescu N, Hahn W, Weinberg R. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 2001; 15(1): 50-65.
27. Mirzai M. Tuberculoma of the cervical spinal canal mimicking en plaque meningioma. J Spinal Disord Tech. 2005; 18(2): 197-199.
28. Yaccoby S, Johnson C, Mahaffey S, Wezeman M, Barlogie B, Epstein, J. Antimyeloma efficacy of thalidomide in the SCID-hu model. Blood. 2002 100: 4162-4168.
29. Barnes N, Warnberg F, Farnie G, White D, Jiang W, Anderson E, Bundred N. Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer. Br J Cancer. 2007; 96(4): 575-582.
30. Lamszus K, Jin L, Fuchs A, Shi E, Chowdhury S, Yao Y, Polverini P, Laterra J, Goldberg I, Rosen E. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest. 1997; 76(3): 339-353.
31. Tada S, Li A, Maiorano D, Mechali M, Blow J. Repression of origin assembly in metaphase depends on inhibition of RLF-B/Cdt1 by geminin. Nat Cell Biol. 2001; 3: 107-113.
32. Gonzalez M, Tachibana K, Chin S, Callagy G, Madine M, Vowler S, Pinder S, Laskey R, Coleman N. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol. 2004; 204(2): 121-130.
33. Wohlschlegel J, Kutok J, Weng A, Dutta A. Expression of geminin as a marker of cell proliferation in normal tissues and malignancies. Am J Pathol. 2002; 161(1): 267-273.
34. Chang H, Nuyten D, Sneddon J, Hastie T, Tibshirani R, Sørlie T, Dai H, He YD, van t Veer LJ, Bartelink H, van de Rijn M, Brown PO, van de Vijver MJ. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA. 2005; 102: 3738-3743.
35. Chin K, DeVries S, Fridlyand J, Spellman P, Roydasgupta R, Kuo WL, Lapuk A, Neve RM, Qian Z, Ryder T, Chen F, Feiler H, Tokuyasu T, Kingsley C, Dairkee S, Meng Z, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell. 2006. 10: 529-541.
36. van 't Veer L, Dai H, van de Vijver H, He Y, Hart A, Mao M, Peterse H, van der Kooy K, Marton M, Witteveen A. Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend S. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002; 415: 530- 536.
37. Weaver B, Silk A, Montagna C, Verdier-Pinard P, Cleveland D. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell. 2007; 11: 25-36.
38. Guse A, Mishima M, Glotzer M. Phosphorylation of ZEN- 4/MKLP1 by aurora B regulates completion of cytokinesis. Curr Biol. 2005; 15: 778-786.
39. Meraldi P, Honda R, Nigg E. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/-cells. EMBO J. 2002; 21: 483-492.
40. Lampson M, Renduchitala K, Khodjakov A, Kapoor T. Correcting improper chromosome-spindle attachments during cell division. Nat Cell Biol. 2004; 6: 232-237.
41. Lang J-Y, Hsu J, Maric-Bernstam F, Chang C-J, Wang Q, Bao Y, Yamaguchi H, Xie X, Woodward W, Yu D, Hortobagyi GN, Hung MC. BikDD eliminates Breast Cancer Initiating Cells and Synergize with Lapatinib for Breast Cancer Treatment. Cancer Cell. 2011; 20: 341-356.
42. Dobles M, Liberal V, Scott M, Benezra, Sorger R. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell. 2000; 101: 635- 645.
43. Wang Q, Liu T, Fang Y, Xie S, Huang X, Mahmood R, Ramaswamy G, Sakamoto K-M, Darzynkiewicz Z, Xu M, Dai W. BUBR1 deficiency results in abnormal megakaryopoiesis. Blood. 2004; 103: 1278-1285.
44. Baker D, Jeganathan K, Cameron J, Thompson M, Juneja S, Kopecka A, Kumar R, Jenkins R, de Groen P, Roche P, van Deursen J. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet. 2004; 36: 744-749.
45. Michel L, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger P, Murty V, Benezra R. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature. 2001; 409: 355-359.
46. Dai W, Wang Q, Liu T, Swamy M, Fang Y, Xie S, Mahmood R, Yang Y, Xu M. Rao C. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res. 2004; 64: 440-445.